Carcinoembryonic Antigen (CEA)
CD66E; CD66; CEACAM5; Carcinoembryonic Antigen-related Cell Adhesion Molecule 5
 HGNC 1817
 MGI 1920500
 OMIM 114890
 RGD 67396
 UCSC uc002orl.1
 UniProt P06731
 USCN 90150
Carcinoembryonic Antigen (CEA)
Carcinoembryonic antigen (CEA) is a cell-surface glycoprotein with a molecular weight of 180-200kD, that occurs in high levels in colon epithelial cells during embryonic development. Levels of CEA are significantly lower in colon tissue of adults, but can become elevated when inflammation or tumours arise in any endodermal tissue, including the gastrointestinal tract, respiratory tract, pancreas and breast.An overexpression of CEA protein has been detected in a variety of adenocarcinomas, including gastric, pancreatic, small intestine, colon, rectal, ovarian, breast, cervical and non-small-cell lung cancers.
CEA is also expressed by epithelial cells in several non-malignant disorders, including diverticulitis, pancreatitis, inflammatory bowel disease, cirrhosis, hepatitis, bronchitis and renal failure and also in heavy smokers.
Research reagent products of Carcinoembryonic Antigen (CEA)
Organism
ELISA Kit
CLIA Kit
Protein
Antibody
Catalog Manual Catalog Manual Catalog Manual McAb PcAb
Homo sapiens (Human)E90150HuPDFn/an/aP90150Hu01n/aA90150Hu22A90150Hu01
Mus musculus (Mouse)E90150MuPDFn/an/aP90150Mu01n/an/aA90150Mu01
Rattus norvegicus (Rat)E90150RaPDFn/an/aP90150Ra01n/an/aA90150Ra01